Sai Reddy

Gründer bei

Engimmune Therapeutics AG

Consumer Services

Finance

Commercial Services

Profil

Sai Reddy is the founder of Engimmune Therapeutics AG, founded in 2021, holding the title of Director since 2021.
Dr. Reddy currently holds the positions of Chairman at deepCDR Biologics AG and Venture Partner at Pureos Partners AG.
Dr. Reddy completed a doctorate degree at École Polytechnique Fédérale de Lausanne in 2008 and an undergraduate degree at Northwestern University in 2003.

Aktive Positionen von Sai Reddy

Unternehmen	Position	Beginn
deepCDR Biologics AG deepCDR Biologics AG Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies	Vorsitzender	-
Engimmune Therapeutics AG Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers	Gründer	01.01.2021
Pureos Partners AG Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions.	Private Equity Investor	-

Alle aktiven Positionen von Sai Reddy

Ausbildung von Sai Reddy

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Sai Reddy im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
École Polytechnique Fédérale de Lausanne École Polytechnique Fédérale de Lausanne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Northwestern University Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pureos Partners AG Pureos Partners AG Investment ManagersFinance Pureos Partners invests in companies located in Switzerland. The firm focuses on drug development companies. It participates in early stage capital transactions.	Finance
deepCDR Biologics AG deepCDR Biologics AG Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies	Commercial Services
Engimmune Therapeutics AG Engimmune Therapeutics AG BiotechnologyHealth Technology Develops drugs to treat tumor cancers	Health Technology